1-2 of 2
Rujin Cheng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Bi-Specific T-Cell Engager Targeting ILT3 Is Potently Effective in Multiple Myeloma

Francesco Di Meo, Anjushree Iyer, Keith Akama, Christina Yu, Rujin Cheng, Annamaria Cesarano, Silvia Marino, Arafat Aljoufi, Rajesh Soni, Julie M Roda, James Sissons, Ly P Vu, Monica L. Guzman, Kun Huang, David G. Roodman, Fabiana Perna
Journal: Blood
Blood (2022) 140 (Supplement 1): 671–672.
https://doi.org/10.1182/blood-2022-167584
Published: 2022
Journal Articles

Preclinical Characterization of NGM936, a Novel Bispecific T Cell Engager Targeting ILT3 for the Treatment of Acute Myeloid Leukemia with Monocytic Differentiation

Vicky Y Lin, Anjushree Iyer, Keith Akama, Rujin Cheng, Hong Yang, Jonathan Aguayo, Betty Li, Alan K Kutach, Jie Tang, Daniel Kaplan, Julie M Roda
Journal: Blood
Blood (2022) 140 (Supplement 1): 9063–9064.
https://doi.org/10.1182/blood-2022-160209
Published: 2022